COVID-19 in rheumatoid arthritis: prevalence, hospital admission, and risk of all-cause mortality before and after COVID-19 pandemic
COVID-19 was higher in females, younger patients, those with comorbidities, and those using advanced therapies. Compared to pre-pandemic, higher death rates during the pandemic were associated with older age, oral steroid use, smoking, and higher disease activity.
Authors
- Sibel Zehra Aydın (ORCID: https://orcid.org/0000-0001-8792-4449)
- Mohammad Movahedi (ORCID: https://orcid.org/0000-0001-6154-0121)
- Xiuying Li (ORCID: https://orcid.org/0000-0002-7025-6306)
- Claire Bombardier (ORCID: https://orcid.org/0000-0001-5083-2137)
- Elliot Hepworth
- Angela Cesta
Institutions
- Toronto General Hospital (CA)
- Toronto General Hospital Research Institute
Publication Details
- Journal
- Clinical and Experimental Rheumatology
- Published
- 2025-03-25
- DOI
- https://doi.org/10.55563/clinexprheumatol/00jq99
- Citations
- 1
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 1.67